
Amanda Marie Haney
Examiner (ID: 4279, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1000 |
| Issued Applications | 285 |
| Pending Applications | 140 |
| Abandoned Applications | 613 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17673129
[patent_doc_number] => 20220186296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MULTIPLEXED SIGNAL AMPLIFICATION METHODS USING ENZYMATIC BASED CHEMICAL DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/433542
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433542 | MULTIPLEXED SIGNAL AMPLIFICATION METHODS USING ENZYMATIC BASED CHEMICAL DEPOSITION | Feb 24, 2020 | Pending |
Array
(
[id] => 16238677
[patent_doc_number] => 20200255911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Method for Using Gene Expression to Determine Prognosis of Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 16/800292
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800292
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800292 | Method for Using Gene Expression to Determine Prognosis of Prostate Cancer | Feb 24, 2020 | Abandoned |
Array
(
[id] => 17497836
[patent_doc_number] => 11286529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Diagnostic methods for infectious disease using endogenous gene expression
[patent_app_type] => utility
[patent_app_number] => 16/797733
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 45
[patent_no_of_words] => 21397
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797733 | Diagnostic methods for infectious disease using endogenous gene expression | Feb 20, 2020 | Issued |
Array
(
[id] => 17548552
[patent_doc_number] => 20220119893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => PROCESS FOR CLASSIFICATION OF GLIOMA
[patent_app_type] => utility
[patent_app_number] => 17/432813
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432813
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432813 | PROCESS FOR CLASSIFICATION OF GLIOMA | Feb 18, 2020 | Pending |
| 16/794754 | DETECTION AND CLASSIFICATION OF IMP CARBAPENEMASES USING REAL-TIME POLYMERASE CHAIN REACTION ASSAY | Feb 18, 2020 | Abandoned |
Array
(
[id] => 17386055
[patent_doc_number] => 20220033907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 17/430877
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430877 | BIOMARKERS | Feb 13, 2020 | Abandoned |
Array
(
[id] => 17946144
[patent_doc_number] => 20220333161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS FOR PREDICTING THE RISK OF PROGRESSION AND PHARMACOLOGICAL RESPONSE OF A HUMAN SUBJECT SUFFERING FROM RELAPSING-REMITTING MULTIPLE SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 17/429906
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429906 | METHODS FOR PREDICTING THE RISK OF PROGRESSION AND PHARMACOLOGICAL RESPONSE OF A HUMAN SUBJECT SUFFERING FROM RELAPSING-REMITTING MULTIPLE SCLEROSIS | Feb 10, 2020 | Pending |
Array
(
[id] => 17579209
[patent_doc_number] => 20220136064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS AND PROGNOSIS
[patent_app_type] => utility
[patent_app_number] => 17/429279
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429279 | COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS AND PROGNOSIS | Feb 9, 2020 | Pending |
Array
(
[id] => 20372737
[patent_doc_number] => 12480164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => DNA methylation biomarkers for early detection of cervical cancer
[patent_app_type] => utility
[patent_app_number] => 17/299132
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7644
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299132 | DNA methylation biomarkers for early detection of cervical cancer | Feb 3, 2020 | Issued |
Array
(
[id] => 18227293
[patent_doc_number] => 20230066287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => BIOMARKERS FOR RENAL CELL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/423029
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423029 | BIOMARKERS FOR RENAL CELL CARCINOMA | Jan 15, 2020 | Pending |
Array
(
[id] => 17657507
[patent_doc_number] => 20220177972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP4
[patent_app_type] => utility
[patent_app_number] => 17/309901
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309901 | METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP4 | Dec 29, 2019 | Pending |
Array
(
[id] => 18461666
[patent_doc_number] => 11685950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Method of diagnosing and treating acute rejection in kidney transplant patients
[patent_app_type] => utility
[patent_app_number] => 16/727281
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7044
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727281 | Method of diagnosing and treating acute rejection in kidney transplant patients | Dec 25, 2019 | Issued |
Array
(
[id] => 16269201
[patent_doc_number] => 20200270688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720403
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720403 | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16073193
[patent_doc_number] => 20200190583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => Methods and Compositions for Sequentially Detecting Targets
[patent_app_type] => utility
[patent_app_number] => 16/713760
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713760 | Methods and compositions for sequentially detecting targets | Dec 12, 2019 | Issued |
Array
(
[id] => 16238672
[patent_doc_number] => 20200255906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 16/709780
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16709780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/709780 | Extract from a body fluid comprising a micro RNA | Dec 9, 2019 | Issued |
Array
(
[id] => 16269200
[patent_doc_number] => 20200270687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 16/707584
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707584 | Cystic fibrosis transmembrane conductance regulator gene mutations | Dec 8, 2019 | Issued |
Array
(
[id] => 17299981
[patent_doc_number] => 20210395820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHOD OF EVALUATING FEMALE REPRODUTIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/293281
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293281 | METHOD OF EVALUATING FEMALE REPRODUTIVE FUNCTION | Dec 5, 2019 | Abandoned |
Array
(
[id] => 17428797
[patent_doc_number] => 20220056505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Methods for Detecting Cell Wall-Deficient Bacteria (CWDB) in Biological Samples
[patent_app_type] => utility
[patent_app_number] => 17/299885
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299885 | Methods for Detecting Cell Wall-Deficient Bacteria (CWDB) in Biological Samples | Dec 4, 2019 | Pending |
Array
(
[id] => 20343354
[patent_doc_number] => 12467077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Compositions and methods for DNA modification detection
[patent_app_type] => utility
[patent_app_number] => 17/293869
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 14710
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293869 | Compositions and methods for DNA modification detection | Nov 17, 2019 | Issued |
Array
(
[id] => 18643499
[patent_doc_number] => 11767560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Diagnostic and treatment method for endometrial cavity distorting uterine leiomyoma using microRNA
[patent_app_type] => utility
[patent_app_number] => 16/565443
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 3612
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565443 | Diagnostic and treatment method for endometrial cavity distorting uterine leiomyoma using microRNA | Nov 14, 2019 | Issued |